Clinical Trials Directory

Trials / Unknown

UnknownNCT04070872

3-dimensional Versus 2-dimensional Laparoscopy for Hysterectomy

3-dimensional Versus 2-dimensional Laparoscopy for Hysterectomy: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Kangbuk Samsung Hospital · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the surgical outcomes and efficacy of 3-dimensional (3D) versus 2-dimensional (2D) imaging systems in laparoscopic hysterectomy.

Detailed description

Laparoscopy is founded as a treatment of choice for benign uterine disease. The advantages of laparoscopic surgery over conventional open surgery are less pain, shorter recovery time, shorter hospital stay, and consequently faster return to normal activity as well as better cosmetic effects. However, laparoscopic surgery is more demanding compared with open surgery because operators should project three-dimensional (3D) field through a two-dimensional (2D) monitor. However, to date, studies examining the possible benefits and drawbacks of 3D imaging system versus 2D in laparoscopic surgery have brought about conflicting results. Moreover, there have been few studies comparing the surgical outcomes of 3D and 2D laparoscopic laparoscopic hysterectomy. The aim of this study is to compare the surgical outcomes and efficacy of 3-dimensional (3D) versus 2-dimensional (2D) imaging systems in laparoscopic hysterectomy.

Conditions

Interventions

TypeNameDescription
PROCEDURE3D laparoscopeFor laparoscopic camera system, a 10-mm ENDOEYE FLEX 3D Deflectable Videoscope (Olympus Corp., Germany) was used in the 3D group.
PROCEDURE2D laparoscopeFor laparoscopic camera system, a 10-mm 30º IDEAL EYES Laparoscope (Stryker, Kalamazoo, MI, USA) camera was used in the 2D group.

Timeline

Start date
2019-08-23
Primary completion
2019-08-23
Completion
2019-08-23
First posted
2019-08-28
Last updated
2019-08-28

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04070872. Inclusion in this directory is not an endorsement.